Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Total Consolidated Revenue by Year
Total Consolidated Revenue — Disaggregated by Payer & Product ($M) ($M)
Natera Total Consolidated Revenue: $2,306M in FY2025, up 35.9% from a year earlier. That is the highest of the 13 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K/10-Q Consolidated Statements of Operations & Revenue Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Consolidated Revenue — Disaggregated by Payer & Product ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,306 | +35.9% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 1,697 | +56.7% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 1,083 | +32.0% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 820 | +31.1% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 626 | +60.0% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 391 | +29.3% | Form 10-K (2021-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 302 | +17.3% | Form 10-K (2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | 258 | +22.9% | Form 10-K (2019-03-15) ↗ |
| FY2017 | Dec 31, 2017 | 210 | -1.4% | Form 10-K (2019-03-15) ↗ |
| FY2016 | Dec 31, 2016 | 213 | +11.6% | Form 10-K (2019-03-15) ↗ |
| FY2015 | Dec 31, 2015 | 190 | +19.5% | Form 10-K (2016-03-24) ↗ |
| FY2014 | Dec 31, 2014 | 159 | +188.6% | Form 10-K (2016-03-24) ↗ |
| FY2013 | Dec 31, 2013 | 55.2 | – | Form 10-K (2016-03-24) ↗ |
Breakdown
What makes up total Consolidated Revenue
- Insurance Carriers Revenue — Third-Party Commercial & Government Payers ($M)2,171 · FY2025
- Laboratory Partners & Hospitals Revenue — Institutional Payers ($M)103 · FY2025
- Patients Revenue — Self-Pay & Out-of-Pocket Co-Pays ($M)31.8 · FY2025
- Panorama Non-Invasive Prenatal Test (NIPT) Revenue ($M) [legacy through Q3 2019]141 · FY2018
- Horizon Carrier Screening (HCS) Revenue ($M) [legacy through Q3 2019]87.2 · FY2018
- Other Genetic Tests Revenue ($M) [legacy through Q3 2019]12.3 · FY2018
- Constellation Cloud Software Platform Revenue ($M) [legacy through Q3 2019]4.84 · FY2018
- Other Licensing & Services Revenue ($M) [legacy through Q1 2020]11.0 · FY2019
Cite this data
StockData. (2026). Natera Total Consolidated Revenue ($M), annual FY2013–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-payer-disagg-parent
See every metric in the Natera KPI table. Data updated Nov 2, 2026.